CClinicalTrials.gg
CompletedNCT04544761Updated Mar 20, 2026

Resilience in Persons Following Spinal Cord Injury

An observational study in Spinal Cord Injuries, sponsored by Shirley Ryan AbilityLab. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-03-20.

Sponsored by Shirley Ryan AbilityLab · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
28
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This study aims to quantify resilience in survivors of a spinal cord injury. The study will consist of structured interviews and self-reported surveys. We will look for common themes between participants at different stages of injury (1-5 years, 5-15 years, >15 Years).

Read the detailed description

The goal of this project is to broaden the understanding of the lived experience of aging with a disability, from the perspectives of individuals with physical disabilities resulting from spinal cord injury (SCI). The specific objectives of this project are to:

  1. Learn how people with SCI attain and maintain optimal quality of life as they age.
  2. Understand how people with SCI develop resilience as they grow older.
  3. Understand how individual quality of life is related to the degree and mechanism of resilience among people with SCI.
  4. Learn which resources and practices have been most helpful and useful to people with SCI as they age with their disability.
  5. Assess personal, behavioral, and environmental factors that contribute to resilience and quality of life among people aging with SCI.
  6. Refine and confirm a holistic model for the relationships among the concepts of resilience, quality of life, and person-centered factors (resources, behaviors).

Through in-depth interviews and detailed surveys, we will explore how people with SCI attain and maintain optimal quality of life as they age, and how their quality of life relates to resiliency as they traverse the path of aging with SCI. We will explore with participants the resources and practices that have been most helpful and useful to them as they age with their disability.

02

Conditions studied

  • Spinal Cord Injuries

Keywords

  • Resilience
03

In context

Spinal Cord Injuries

1,948 studies on the registry are indexed under Spinal Cord Injuries; 505 are open to participants now.

This study's enrollment of 28 is below the median of 60 across 323 observational studies indexed under Spinal Cord Injuries.

Browse Spinal Cord Injuries studies →

Lead sponsor

Shirley Ryan AbilityLab is the lead sponsor of 177 studies on the registry; 43 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 4 (40%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Persons who have experienced spinal cord injury at least 1 year prior to enrollment

Eligibility criteria

Inclusion Criteria:

  • 18-80 years old
  • History of Traumatic Spinal Cord Injury at least 1 year prior
  • Ability to self-report on factors affecting health and well being Exclusion Criteria
  • Progressive Spinal Cord Injury
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
28 participants (actual)
Patient registry
No

Groups and cohorts

  • 1-5 Years post

    Persons with Spinal Cord Injury occurring between 1-5 years prior

    Other: Structured Interview

  • 5-15 Years post

    Persons with Spinal Cord Injury occurring between 5-15 years prior

    Other: Structured Interview

  • >15 Years post

    Persons with Spinal Cord Injury occurring at least 15 years prior

    Other: Structured Interview

Interventions

  • OtherStructured Interview

    Structured interview with research staff about your experience living with spinal cord injury

06

What researchers measure

Primary outcomes

  1. Themes Survey

    Common themes from the structured interviews

    Time frame: 1 day (Single time point)

Secondary outcomes

  1. Resilience

    Measure of resilience from Connor-Davidson Resilience Scale \[0-40\], low score indicates greater resilience

    Time frame: 1 day (Single time point)

Other outcomes

  1. Health Questionnaire Surveys

    Short Form-12 Health Survey \[30-70\] 50 indicates US average, values higher than 50 indicate better outcomes

    Time frame: 1 day (Single time point)

07

Study locations

1 site
  • Shirley Ryan AbilityLab
    Chicago, Illinois 60611, United States
08

References and documents

Publications

  • Roth EJ, Lovell L, Barry A. Perspectives on factors influencing quality of life in persons with long-term spinal cord injury: a qualitative study. Spinal Cord. 2024 Jun;62(6):343-347. doi: 10.1038/s41393-024-00991-w. Epub 2024 Apr 22. PubMed 38649756 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04544761
Lead sponsor
Shirley Ryan AbilityLab
Collaborators
Kiwanis Neurological Research Foundation
Responsible party
Elliot Roth (Co-Medical Director, Brain Innovation Center, Shirley Ryan AbilityLab) — Principal investigator
First posted
Sep 10, 2020
Start date
Sep 25, 2020
Primary completion
Oct 1, 2022
Completion
Apr 4, 2024
Last update
Mar 20, 2026

Study contacts

Elliot Roth, MD
principal investigator · Shirley Ryan AbilityLab

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion